These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6414313)

  • 21. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of epinephrine and perfusion pressure on the peak aortic pressure development and glucose transport in the isolated perfused heart of normal and diabetic rats.
    Murthy VK; Bauman MD; Shipp JC
    Basic Res Cardiol; 1983; 78(3):281-8. PubMed ID: 6615400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour.
    Sills T; Heptinstall S
    Thromb Haemost; 1986 Jun; 55(3):305-8. PubMed ID: 3018954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in cardiovascular sensitivity of alloxan-treated diabetic rats to arachidonic acid.
    Boura AL; Hodgson WC; King RG
    Br J Pharmacol; 1986 Nov; 89(3):613-8. PubMed ID: 3099877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dazoxiben on platelet-vessel wall interaction.
    Davies JA; Menys VC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):45S-46S. PubMed ID: 6681703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of arachidonic acid metabolites on cardiac alpha 1-adrenoceptor responses in diabetic rats.
    Xiang H; McNeill JH
    Can J Physiol Pharmacol; 1992 May; 70(5):680-6. PubMed ID: 1330257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasoactive eicosanoids in the rat heart: clues to a contributory role of cardiac thromboxane to post-ischaemic hyperaemia.
    Giannessi D; Lazzerini G; Sicari R; DeCaterina R
    Pharmacol Res; 1992 Dec; 26(4):341-56. PubMed ID: 1294940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilative and anti-adrenergic effects of adenosine in diabetic rat hearts.
    Warner EL; Galasso F; Thompson CI; Belloni FL
    Can J Physiol Pharmacol; 1992 Jan; 70(1):13-9. PubMed ID: 1316217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostaglandin involvement in hypersensitivity of ischemic hearts to arrhythmogenic influence of ouabain.
    Moffat MP; Karmazyn M; Ferrier GR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H57-63. PubMed ID: 3925797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The positive inotropic effect of sodium arachidonate on auricles from diabetic rats.
    Canga L; Sterin-Borda L; Borda ES; Peredo H; Gimeno AL
    Eur J Pharmacol; 1985 Mar; 110(1):47-54. PubMed ID: 3924636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets.
    Siewiera K; Kassassir H; Talar M; Wieteska L; Watala C
    Platelets; 2016; 27(3):203-11. PubMed ID: 26325148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
    Ioannou P; Talesnik J
    Can J Physiol Pharmacol; 1986 Apr; 64(4):398-405. PubMed ID: 2425912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of alloxan- and streptozotocin-induced diabetes on isolated rat heart responsiveness to carbachol.
    Vadlamudi RV; McNeill JH
    J Pharmacol Exp Ther; 1983 May; 225(2):410-5. PubMed ID: 6341541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arachidonic acid causes postischemic dysfunction in control but not diabetic hearts.
    Pieper GM
    Am J Physiol; 1990 Apr; 258(4 Pt 2):H923-30. PubMed ID: 2109941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of platelet thromboxane synthetase by 1-(3-benzyloxy-1[E]octenyl)imidazole.
    Sincholle D; Coquelet C; Bonne C
    Arzneimittelforschung; 1986; 36(1):117-9. PubMed ID: 3082339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of the low thyroid state in diabetes mellitus on cardiac function and inotropic responsiveness to alpha 1-adrenoceptor stimulation: comparison with the role of hypothyroidism alone.
    Beenen OH; Pfaffendorf M; van Zwieten PA
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):553-7. PubMed ID: 8891881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats.
    Gerrard JM; Stuart MJ; Rao GH; Steffes MW; Mauer SM; Brown DM; White JG
    J Lab Clin Med; 1980 Jun; 95(6):950-8. PubMed ID: 6445927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.